The complete absence of statin-mediated modulation of PAR-1 expression at both protein and mRNA levels, demonstrated across two distinct CRC cellular phenotypes, unequivocally establishes that the suppressive effects of statins on PAR signaling are specific to the PAR-2 axis. This evidence concerns the gene F2RL1 and colorectal carcinoma.